This is the fifth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?", featuring expert dermatologist Dr. Naiem Issa, MD, PhD, discusses the following topics:

1. Mechanistic differences between JAKi and biologics for treatment of AD

2. Clinical data supporting the safety of JAKi in head-to-head trials compared to biologics

3. Pearls for prescribing JAKi to AD patients

4. Strategies for choosing JAKi vs biologics based on safety and patient factors